|
|
||||||||
The Annals of Thoracic Surgery, Vol 55, 159-161, Copyright © 1993 by The Society of Thoracic Surgeons
CM Jost, CW Yancy Jr and WS Ring
Prosthetic valve thrombosis is associated with high mortality. The
treatment of choice remains operation. This is a case report of the
successful combination therapy of tissue plasminogen activator and
urokinase for an isolated thrombosed prosthetic mitral valve in a
postpartum patient in whom operation was thought to carry an unacceptable
risk. Combined thrombolytic therapy or therapy with a single agent with a
long half-life and a prolonged infusion time is suggested as an emergent
treatment option for prosthetic mitral valve thrombosis.
ARTICLES
Combined thrombolytic therapy for prosthetic mitral valve thrombosis
Department of Internal Medicine, UT Southwestern Medical Center, Dallas 75235-9034.
This article has been cited by other articles:
![]() |
R. Roudaut, S. t. Lafitte, M.-F. Roudaut, C. Courtault, J.-M. Perron, C. Jais, X. Pillois, P. Coste, and A. DeMaria Fibrinolysis of mechanical prosthetic valve thrombosis: A single-center study of 127 cases J. Am. Coll. Cardiol., February 19, 2003; 41(4): 653 - 658. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |